Chris Penland, based in Watertown, MA, US, is currently a Senior Group Director, Clinical Pharmacology and Pharmacometrics at Astrazeneca, bringing experience from previous roles at Astrazeneca, Novartis and Epix Pharmaceuticals. Chris Penland holds a 2014 - 2015 University Of California - San Francisco. With a robust skill set that includes Research, Biopharmaceuticals, Clinical Development, Lifesciences, Printing and more, Chris Penland contributes valuable insights to the industry. Chris Penland has 2 emails and 1 mobile phone number on RocketReach.